Report Highlights
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Report Includes
- 92 data tables and 53 additional tables
- Analyses of the global market trends for intravenous (IV) therapy and venous access devices, with revenue data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type, application, end user and region
- Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
- Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
- Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Patent analysis featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Company profiles, including Becton, Dickinson (BD), B. Braun, Fresenius SE & Co. KGaA, Baxter and Medtronic
Report Scope
This report examines the global market for IV therapy and venous access devices, providing a comprehensive review of applications across several healthcare facility settings.
The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of IV solutions. These include general IV solutions, parenteral nutrition IV solutions and premixed drug IV solutions; infusion pumps such as general infusion pumps, specialized infusion pumps, portable and disposable infusion pumps, and implantable infusion pumps; and venous access devices such as peripheral IV catheters and central venous catheters.
- Products for each IV solution and set market segment include:
- General IV solutions and sets: Includes normal saline, hypertonic saline, Lactated Ringer’s, Dextran and dextrose in water, along with IV sets, containers and accessories for care settings.
- Parenteral nutrition IV solutions and sets: Covers nutrient-rich solutions (carbohydrates, lipid emulsions, amino acids, trace elements, vitamins, minerals) with accompanying IV sets and accessories for care settings.
- Premixed IV solutions and sets: Includes premixed drugs (antibiotics, pain management, cardiovascular agents) with drug-delivery systems, containers, and accessories for care settings.
This report addresses regulatory aspects, including technological advances (patents and approvals), and the latest trends, preferences and developments in IV therapy. It includes market projections and market share analysis for global IV therapy and venous access market. It covers emerging technologies, such as AI-integrated ultrasonography for automatic vein measurement to prevent IV catheter failure, and AI-enabled, ultrasound-guided handheld robotic devices for femoral vascular. The market is segmented by region into North America, Asia-Pacific, Europe, and Rest of the World (RoW), and analyzes the markets for the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||
| Base year market size | $54.4 billion | ||||||||||||||||
| Market size forecast | $74.4 billion | ||||||||||||||||
| Growth rate | CAGR of 5.5% for the forecast period of 2024-2029 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product Type, Application, and Region | ||||||||||||||||
| Regions covered | North America, Asia-Pacific, Europe, and Rest of the World (RoW) | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, China, Middle East, and Africa | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Growing aging population
- Growing prevalence of chronic diseases
- Growth of alternative site and home-based medical care
- Growing health care spending in emerging Markets.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for IV therapy and vein access will grow from nearly $40.7 billion in 2018 to $54.5 billion by 2023 with a compound annual growth rate (CAGR) of 6.0% for the period of 2018-2023.
Report Highlights
The global intravenous (IV) therapy and vein access market should reach $29 billion by 2021 from $21.6 billion in 2016 at a compound annual growth rate (CAGR) of 6.1%, from 2016 to 2021.
Report Highlights
The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering a compound annual growth (CAGR) of 6.0% over the next five years.
Report Highlights
- In 2009, the total global intravenous therapy and vein access market reached nearly; $8.8 billion and is forecast to reach $11.2 billion in 2014, a compound annual growth rate (CAGR) of 5%.
- Insulin-infusion pumps are expected to show the greatest demand over the forecast period. This segment was worth $1.1 billion in 2009 and is expected to increase at an 8.1% compound annual growth rate (CAGR) to reach $1.6 billion in 2014.
- The central venous access devices and implantable pumps segment will experience a 5.7% compound annual growth rate (CAGR) over the forecast period. This market was valued at $975 million in 2009 and is expected to reach a value of nearly $1.3 billion in 2014.
Report Highlights
-
U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
-
The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
-
The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.
Related Reports
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Recent Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Global Colorectal Cancer Screening and Diagnostics Market
The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.
Medical Imaging: A BCC Research Outlook
The global market for medical imaging is expected to grow from $63.4 billion in 2024 and is projected to reach $82.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More